Phase I trial of the fusion peptide AC 165198 for diabetes mellitus
Latest Information Update: 08 Feb 2012
At a glance
- Drugs BMS 986125 (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
Most Recent Events
- 08 Feb 2012 New trial record